Malignant melanoma is the skin cancer with the highest mortality rate and increasing prevalence. Melanoma has clinical and pathological subtypes. Criteria have been defined for early and histopathological diagnosis of malignant melanoma. Many treatments according to stage and clinical characteristics have been developed. Particularly, Today, thanks to immunotherapy of late-stage cancer, progression of the disease has halted and survival time has significantly increased.